search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    Arcturus Therapeutics Holdings Inc.

    (NASDAQ:ARCT)

    $18.9

    $2.74

    16.96%

    Arcturus Therapeutics Holdings Inc. Chart

    ARCT Stock Price Today

    Arcturus Therapeutics Holdings Inc. (ARCT) stock rallied over 16.96% intraday to trade at $18.90 a share on NASDAQ. The stock opened with a gain of 20.38% at $15.64 and touched an intraday high of $18.9, rising 16.96% against the last close of $16.16. The stock went to a low of $15.5 during the session.

    Stock Snapshot

    $16.16

    Prev. Close

    486.3 Million

    Market Cap

    $15.5

    Day Low

    $15.64

    Open

    26.38 Million

    Number of Shares

    $18.9

    Day High

    -

    P/E ratio

    -7.53

    EPS (TTM)

    14.05

    Cash Flow per Share

    14.85

    Free Float in %

    9.83

    Book Value

    714,802

    Volume

    Arcturus Therapeutics Holdings Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-05$15.64$18.9$15.5$18.9662,980
    2022-07-01$15.7$16.56$15.23$16.16683,500
    2022-06-30$14.92$16$14.65$15.74373,300
    2022-06-29$14.98$15.68$14.55$15.4349,800
    2022-06-28$16.28$16.37$14.81$15.07400,700
    2022-06-27$15.89$16.44$15.25$16.17454,500
    2022-06-24$16.43$16.58$15.03$16.141,814,400
    2022-06-23$15.66$16.18$14.95$16.02889,400
    2022-06-22$14.01$16.11$13.88$15.43791,100
    2022-06-21$13.88$15.64$13.88$14.561,915,000

    Contact Details

    10628 Science Center Drive
    Suite 250
    San Diego, CA 92121
    United States

    Webiste:ARCT

    858 900 2660

    Company Information

    Employees-

    Beta2.79

    Sales or Revenue12.36 Million

    5Y Sales Change-9.50%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.

    Frequently Asked Questions

    icon

    What is the current Arcturus Therapeutics Holdings Inc. (ARCT) stock price?

    Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock price is $18.9 as of the last check on Tuesday, July 5. During the trading session, ARCT stock reached the peak price of $18.9 while $15.5 was the lowest point it dropped to.

    icon

    ARCT's industry and sector of operation?

    The NASDAQ listed ARCT is part of Biotechnology industry that operates in the broader Health Care sector. Arcturus Therapeutics Holdings Inc. , an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States.

    icon

    Who are the executives of ARCT?

    Dr. Steven George Hughes M.B.A., M.D.
    Chief Medical Officer
    Ms. Neda Safarzadeh
    Sr. Director and Head of Investor Relations/PR & Marketing
    Dr. Nirdosh Jagota Ph.D.
    Exec. VP & Chief Regulatory Officer
    Mr. Joseph E. Payne M.Sc.
    Founder, Pres, CEO & Director

    icon

    What is the ARCT stock price today?

    ARCT stock traded closed the last session at $18.9, which is $2.74 or 16.96% lower than its previous close of $16.16. ARCT's current trading price is 61.54% lower than its 52-week high of $65.00 where as its distance from 52-week low of 11.70% is -70.92%.

    icon

    How many employees does ARCT have?

    Number of ARCT employees currently stands at -. ARCT operates from 10628 Science Center Drive, Suite 250, San Diego, CA 92121, United States.

    icon

    Link for ARCT official website?

    Official Webiste of $ARCT is: https://arcturusrx.com

    icon

    How do I contact ARCT?

    ARCT could be contacted at ARCT operates from 10628 Science Center Drive, Suite 250, San Diego, CA 92121, United States, or at phone #858 900 2660 and can also be accessed through its website.

    icon

    How many shares of ARCT are traded daily?

    ARCT stock volume for the day was 714,802 shares while in the previous session number of ARCT shares traded was 662,980 . The average number of ARCT shares traded daily for last 3 months was 759.16 Thousands.

    icon

    How much did ARCT change today?

    The percentage change in ARCT stock occurred in the recent session was 16.96% while the dollar amount for the price change in ARCT stock was $2.74.

    icon

    What price range ARCT stock been trading in?

    In the recent session, the day high for ARCT stock was $18.9 while the low for ARCT stock touched on the day was $15.5.

    icon

    What is the market cap of ARCT currently?

    The market value of ARCT currently stands at 486.3 Million with its latest stock price at $18.9 and 26.38 Million of its shares outstanding.